News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,844 Results
Type
Article (48240)
Company Profile (720)
Press Release (693870)
Multimedia
Podcasts (159)
Webinars (26)
Section
Business (212274)
Career Advice (2871)
Deals (37256)
Drug Delivery (139)
Drug Development (83008)
Employer Resources (179)
FDA (16655)
Job Trends (15985)
News (358143)
Policy (33425)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2229)
Academic (2)
Accelerated approval (34)
Adcomms (26)
Allergies (157)
Alliances (51972)
ALS (186)
Alzheimer's disease (1725)
Antibody-drug conjugate (ADC) (350)
Approvals (16887)
Artificial intelligence (596)
Autoimmune disease (180)
Automation (41)
Bankruptcy (383)
Best Places to Work (11896)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (448)
Bladder cancer (160)
Brain cancer (61)
Breast cancer (657)
Cancer (5021)
Cardiovascular disease (440)
Career advice (2436)
Career pathing (42)
CAR-T (300)
CDC (54)
Celiac Disease (1)
Cell therapy (818)
Cervical cancer (38)
Clinical research (70900)
Collaboration (1871)
Company closure (5)
Compensation (1194)
Complete response letters (73)
COVID-19 (2811)
CRISPR (99)
C-suite (938)
Cystic fibrosis (149)
Data (6449)
Decentralized trials (2)
Denatured (47)
Depression (152)
Diabetes (518)
Diagnostics (6986)
Digital health (51)
Diversity (9)
Diversity, equity & inclusion (42)
Drug discovery (279)
Drug pricing (209)
Drug shortages (33)
Duchenne muscular dystrophy (245)
Earnings (91981)
Editorial (67)
Employer branding (24)
Employer resources (160)
Events (124435)
Executive appointments (1049)
FDA (19883)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1565)
Gene editing (218)
Generative AI (59)
Gene therapy (663)
GLP-1 (1091)
Government (4505)
Grass and pollen (8)
Guidances (383)
Healthcare (18830)
HIV (63)
Huntington's disease (51)
IgA nephropathy (88)
Immunology and inflammation (288)
Immuno-oncology (70)
Indications (126)
Infectious disease (3102)
Inflammatory bowel disease (209)
Inflation Reduction Act (15)
Influenza (123)
Intellectual property (263)
Interviews (550)
IPO (17525)
IRA (57)
Job creations (4479)
Job search strategy (1992)
JPM (71)
Kidney cancer (17)
Labor market (85)
Layoffs (647)
Leadership (41)
Legal (8310)
Liver cancer (95)
Longevity (18)
Lung cancer (669)
Lymphoma (377)
Machine learning (43)
Management (64)
Manufacturing (873)
MASH (175)
Medical device (14472)
Medtech (14536)
Mergers & acquisitions (20828)
Metabolic disorders (1377)
mRNA (186)
Multiple sclerosis (169)
NASH (19)
Neurodegenerative disease (358)
Neuropsychiatric disorders (103)
Neuroscience (3074)
Neurotech (1)
NextGen: Class of 2026 (6915)
Non-profit (4013)
Now hiring (69)
Obesity (670)
Opinion (332)
Ovarian cancer (165)
Pain (215)
Pancreatic cancer (243)
Parkinson's disease (302)
Partnered (37)
Patents (532)
Patient recruitment (528)
Peanut (63)
People (61744)
Pharmaceutical (134)
Pharmacy benefit managers (30)
Phase 1 (22079)
Phase 2 (31277)
Phase 3 (23497)
Pipeline (5722)
Policy (321)
Postmarket research (2504)
Preclinical (9258)
Press Release (68)
Prostate cancer (258)
Psychedelics (57)
Radiopharmaceuticals (309)
Rare diseases (935)
Real estate (6285)
Recruiting (77)
Regulatory (25271)
Reports (46)
Research institute (2180)
Resumes & cover letters (442)
Rett syndrome (28)
RNA editing (20)
RSV (84)
Schizophrenia (161)
Series A (270)
Series B (203)
Service/supplier (27)
Sickle cell disease (106)
Special edition (27)
Spinal muscular atrophy (165)
Sponsored (41)
Startups (4017)
State (2)
Stomach cancer (21)
Supply chain (112)
Tariffs (99)
The Weekly (110)
Vaccines (1103)
Venture capital (100)
Weight loss (448)
Women's health (93)
Worklife (22)
Date
Today (180)
Last 7 days (801)
Last 30 days (2825)
Last 365 days (31565)
2026 (4762)
2025 (31711)
2024 (36802)
2023 (41531)
2022 (52263)
2021 (56411)
2020 (54607)
2019 (47212)
2018 (35969)
2017 (34342)
2016 (33763)
2015 (39425)
2014 (32882)
2013 (28113)
2012 (29395)
2011 (29549)
2010 (27604)
Location
Africa (915)
Alabama (94)
Alaska (7)
Arizona (276)
Arkansas (13)
Asia (44597)
Australia (7409)
California (11874)
Canada (3372)
China (1188)
Colorado (494)
Connecticut (514)
Delaware (354)
Europe (99691)
Florida (1729)
Georgia (370)
Hawaii (4)
Idaho (62)
Illinois (910)
India (77)
Indiana (560)
Iowa (24)
Japan (451)
Kansas (125)
Kentucky (42)
Louisiana (29)
Maine (81)
Maryland (1391)
Massachusetts (8686)
Michigan (358)
Minnesota (657)
Mississippi (5)
Missouri (138)
Montana (36)
Nebraska (26)
Nevada (126)
New Hampshire (85)
New Jersey (3197)
New Mexico (32)
New York (3091)
North Carolina (1610)
North Dakota (9)
Northern California (5778)
Ohio (357)
Oklahoma (23)
Oregon (51)
Pennsylvania (2366)
Puerto Rico (25)
Rhode Island (52)
South America (1301)
South Carolina (68)
South Dakota (1)
Southern California (4572)
Tennessee (176)
Texas (1802)
United States (42181)
Utah (351)
Vermont (1)
Virginia (290)
Washington D.C. (83)
Washington State (980)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
742,844 Results for "yoh a day and zimmermann company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
JPM26 Day 2: Companies Lay Out Near-Term Revenue, Longer-Term Business Goals
Biopharma companies—including AstraZeneca, BioNTech and Agios—peered farther into the future on the second day of JPM, setting both revenue and R&D targets through the end of the decade.
January 14, 2026
·
4 min read
·
Tristan Manalac
Events
JPM26 Day 1: Obesity Front-and-Center, Q4 Sales Beats
Obesity took center stage on the first day of the 2026 J.P. Morgan Healthcare Conference, with industry frontrunners Eli Lilly and Novo Nordisk providing supply chain, regulatory and pricing updates.
January 13, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance
July 10, 2025
·
11 min read
Press Releases
Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day
December 11, 2025
·
7 min read
Business
Ligand Appoints Martine Zimmermann to its Board of Directors
Ligand Pharmaceuticals Incorporated announced the appointment of Martine Zimmermann, PharmD, to its Board of Directors as an independent director.
September 26, 2023
·
3 min read
Biotech Beach
Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs
Gossamer Bio, Inc. announced that Rainer Zimmermann, MD, has joined the Company as Vice President of Medical Affairs.
October 3, 2023
·
5 min read
Press Releases
Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company’s Industry Leading Technology Pipeline at Investor & Analyst Day
November 20, 2025
·
6 min read
Press Releases
Day One Completes Acquisition of Mersana Therapeutics
January 7, 2026
·
7 min read
Press Releases
BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day
February 23, 2026
·
1 min read
Press Releases
Aytu BioPharma Recaps Investor Day Held on January 20, 2026
January 21, 2026
·
29 min read
1 of 74,285
Next
